Results 261 to 270 of about 32,848 (294)

Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy

Anaesthesia, 2009
Summary Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is used for selected gastrointestinal carcinomas. We report a case of ventricular tachycardia during HIPEC with cisplatin that persisted as long as the chemotherapy solution remained in the intra‐abdominal cavity.
C A, Thix, I, Königsrainer, R, Kind, P, Wied, T H, Schroeder   +4 more
openaire   +2 more sources

Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high‐grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study

BJOG: an International Journal of Obstetrics and Gynaecology, 2022
To investigate whether the combination of neoadjuvant hyperthermic intraperitoneal chemotherapy (NHIPEC) plus intravenous neoadjuvant chemotherapy (IV NACT) has superior efficacy to IV NACT alone.
Miao-Fang Wu, Jin-xiao Liang, Hui Li, Yan-Fang Ye, Wei Liang, Li-Juan Wang, Bingzhong Zhang, Qing Chen, Zhongqiu Lin, Jing Li   +9 more
semanticscholar   +1 more source

Hyperthermic Intraoperative Intraperitoneal Chemotherapy Safety Considerations

AORN Journal, 1996
ABSTRACTPerioperative staff members encounter many occupational exposure hazards in the workplace. Cytotoxic agent exposure is a relatively new hazard that perioperative staff members are experiencing as more surgeons use hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) to treat patients with abdominopelvic cavity malignancies. Routes of
S K, White, A D, Stephens, P H, Sugarbaker   +2 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)

Journal of Clinical Oncology
PURPOSE To investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-free survival (PFS), as opposed to SCS alone in ...
MD PhD Anna Fagotti, MD Barbara Costantini, MD PhD Francesco Fanfani, PhD MSc Diana Giannarelli, MD Pierandrea De Iaco, MD PhD Vito Chiantera, MD Vincenzo Mandato, MD Giorgio Giorda, MD Giovanni Aletti, MD PhD Stefano Greggi, MD PhD A. Myriam Perrone, MD Vanda Salutari, MD Rita Trozzi, MD Giovanni Scambia   +13 more
semanticscholar   +1 more source

Hyperthermic Intraperitoneal Chemotherapy

2017
Peritoneal metastasis in abdominal malignancies is associated with a dismal prognosis. In the past, it was considered inoperable and the patient was considered a candidate for palliative chemotherapy alone. The outcome of systemic chemotherapy is poor with the average survival being 6–8 months.
Nikhil Gupta, Shivendra Singh
openaire   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

Diseases of the Colon & Rectum, 2021
BACKGROUND: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Manas Parikh, Paul Johnson, J. Romanes, H. Freitag, M. Spring, N. Garcia-Henriquez, J. Monson   +6 more
semanticscholar   +1 more source

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

Journal of Surgical Oncology, 2021
The PERISCOPE I (Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyPErthermic intraperitoneal chemotherapy) study was conducted to investigate the safety and feasibility of hyperthermic intraperitoneal ...
W. Koemans, R. T. van der Kaaij, E. Wassenaar, D. Boerma, H. Boot, K. Sikorska, M. Los, C. Grootscholten, K. Hartemink, A. Veenhof, Liudmila L. Kodach, P. Snaebjornsson, J. V. van Sandick   +12 more
semanticscholar   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer

Journal of Obstetrics and Gynaecology Research, 2020
AbstractAimHyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its future prospects.MethodsThis article reviews the current literature and evidence for the ...
Hideaki, Tsuyoshi, Daisuke, Inoue, Tetsuji, Kurokawa, Yoshio, Yoshida   +3 more
openaire   +2 more sources

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience

Journal of Surgical Oncology, 2021
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is predominantly performed and studied in academic centers. While developing CRS/HIPEC programs in nonacademic hospitals can increase accessibility, its safety and ...
A. Nikiforchin, V. Gushchin, M. King, E. Baron, C. Nieroda, M. Sittig, A. Sardi   +6 more
semanticscholar   +1 more source

Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis

Diseases of the Colon & Rectum, 2021
Supplemental Digital Content is available in the text. BACKGROUND: Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases have traditionally been contraindicated ...
M. Flood, Atandrila Das, Mikael L Soucisse, Joseph C. H. Kong, R. Ramsay, M. Michael, B. Loveday, S. Warrier, A. Heriot   +8 more
semanticscholar   +1 more source